Cargando…
Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199964/ https://www.ncbi.nlm.nih.gov/pubmed/37014622 http://dx.doi.org/10.1007/s40122-023-00502-4 |
| _version_ | 1785045039909437440 |
|---|---|
| author | Chandler, David Szekely, Christine Aggarwal, Shivani Cyprien, Lori Bensink, Mark |
| author_facet | Chandler, David Szekely, Christine Aggarwal, Shivani Cyprien, Lori Bensink, Mark |
| author_sort | Chandler, David |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10199964 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101999642023-05-22 Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data Chandler, David Szekely, Christine Aggarwal, Shivani Cyprien, Lori Bensink, Mark Pain Ther Correction Springer Healthcare 2023-04-04 2023-06 /pmc/articles/PMC10199964/ /pubmed/37014622 http://dx.doi.org/10.1007/s40122-023-00502-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Chandler, David Szekely, Christine Aggarwal, Shivani Cyprien, Lori Bensink, Mark Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data |
| title | Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data |
| title_full | Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data |
| title_fullStr | Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data |
| title_full_unstemmed | Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data |
| title_short | Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data |
| title_sort | correction to: migraine characteristics, comorbidities, healthcare resource utilization, and associated costs of early users of erenumab in the usa: a retrospective cohort study using administrative claims data |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199964/ https://www.ncbi.nlm.nih.gov/pubmed/37014622 http://dx.doi.org/10.1007/s40122-023-00502-4 |
| work_keys_str_mv | AT chandlerdavid correctiontomigrainecharacteristicscomorbiditieshealthcareresourceutilizationandassociatedcostsofearlyusersoferenumabintheusaaretrospectivecohortstudyusingadministrativeclaimsdata AT szekelychristine correctiontomigrainecharacteristicscomorbiditieshealthcareresourceutilizationandassociatedcostsofearlyusersoferenumabintheusaaretrospectivecohortstudyusingadministrativeclaimsdata AT aggarwalshivani correctiontomigrainecharacteristicscomorbiditieshealthcareresourceutilizationandassociatedcostsofearlyusersoferenumabintheusaaretrospectivecohortstudyusingadministrativeclaimsdata AT cyprienlori correctiontomigrainecharacteristicscomorbiditieshealthcareresourceutilizationandassociatedcostsofearlyusersoferenumabintheusaaretrospectivecohortstudyusingadministrativeclaimsdata AT bensinkmark correctiontomigrainecharacteristicscomorbiditieshealthcareresourceutilizationandassociatedcostsofearlyusersoferenumabintheusaaretrospectivecohortstudyusingadministrativeclaimsdata |